Patents by Inventor Emmanuel DERIVERY

Emmanuel DERIVERY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • De novo designed modular peptide binding proteins by superhelical matching
    Publication number: 20260159549
    Abstract: The disclosure provides polypeptides that bind tripeptide repeat sequences and having an amino acid sequence at least 50%, identical to the amino acid sequence of any one of SEQ ID NO: 1-105, nucleic acids encoding such polypeptides, expression vectors including such nucleic acids, and host cells including such polypeptides, nucleic acids, and/or expression vectors.
    Type: Application
    Filed: October 24, 2023
    Publication date: June 11, 2026
    Inventors: Lansing Joseph STEWART, David BAKER, Kejia WU, Derrick HICKS, TJ BRUNETTE, Daniel Adriano SILVA MANZANO, William H. SHEFFLER, Inna GORESHNIK, Emmanuel DERIVERY, Kerrie MCNALLY, Gira BHABHA, Damian EKIERT, Rachel REDLER, Atty CHANG, Hua BAI
  • TWO COMPONENT CO-ASSEMBLING TWO DIMENSIONAL PROTEIN STRUCTURES
    Publication number: 20230287402
    Abstract: The disclosure provides two-dimensional protein structures including first and second polypeptides that are different, each form homo-oligomers, and interact to form a rigid interface, polypeptide components of such two-dimensional protein structures, and uses thereof.
    Type: Application
    Filed: August 23, 2021
    Publication date: September 14, 2023
    Inventors: Ariel Ben SASSON, David BAKER, William SHEFFLER, Hannele RUOHOLA-BAKER, Logeshwaran SOMASUNDARM, Emmanuel DERIVERY, Joseph WATSON
  • USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES
    Publication number: 20160199445
    Abstract: The present invention relates to the diagnostic and therapeutic uses of Arpin, a protein from the Uncharacterized Protein Family UPF0552, which is a new inhibitor of the Arp2/3 that inhibits cell migration and is associated with the prognosis of cancer.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 14, 2016
    Inventors: Alexis GAUTREAU, Antonina ALEXANDROVA, Sophie VACHER, Carla SOUSA-BLIN, Emmanuel DERIVERY, Roman GORELIK